Date lodged:
2 July 2014
Status:
Completed
Outcome:
Granted with conditions on 24 April 2015
Summary
On 2 July 2014 Medicines Australia sought re-authorisation in respect of Edition 18 of the Medicines Australia Code of Conduct, which is a voluntary industry code of conduct for the prescription medicines industry in Australia.
On 24 April 2015 the ACCC issued a final determination granting conditional authorisation for a period of five years.
In edition 18 of the Code, Medicines Australia proposed to require its member pharmaceutical companies to report certain benefits made to individual healthcare professionals. The conditions of authorisation require:
-Medicines Australia member companies to ensure, before providing a relevant benefit to a healthcare professional, that the benefit will be able to be individually reported
-the transparency data to be published in a common accessible format
-the transparency data to be made publicly available for at least three years from the date of first publication
-Medicines Australia to use reasonable endeavours to establish a central reporting system for reporting this transparency data and provide regular reports on its progress in doing so.
A copy of the determination is available by following the links below.
On 24 April 2015 the ACCC issued a final determination granting conditional authorisation for a period of five years.
In edition 18 of the Code, Medicines Australia proposed to require its member pharmaceutical companies to report certain benefits made to individual healthcare professionals. The conditions of authorisation require:
-Medicines Australia member companies to ensure, before providing a relevant benefit to a healthcare professional, that the benefit will be able to be individually reported
-the transparency data to be published in a common accessible format
-the transparency data to be made publicly available for at least three years from the date of first publication
-Medicines Australia to use reasonable endeavours to establish a central reporting system for reporting this transparency data and provide regular reports on its progress in doing so.
A copy of the determination is available by following the links below.
Applicant(s)
- Medicines Australia Limited
Authorisation number(s)
- A91436
- A91437
- A91438
- A91439
- A91440
Applications
| Document title | Date | |
|---|---|---|
| Request for Interim Authorisation ( PDF 163.75 KB ) | 13 Nov 2014 | |
| Received ( PDF 1.56 MB ) | 2 Jul 2014 |
Decisions
| Document title | Date | |
|---|---|---|
| Final Determination ( PDF 938.19 KB ) | 24 Apr 2015 | |
| Interim Authorisation Decision ( PDF 151.11 KB ) | 4 Dec 2014 | |
| Draft Determination ( PDF 802.16 KB ) | 17 Oct 2014 |
ACCC correspondence
Submissions - before draft decision
Submissions - after draft decision
Pre-decision conferences
| Document title | Date | |
|---|---|---|
| Pre-decision Conference Minutes ( PDF 173.85 KB ) | 2 Dec 2014 | |
| Certificate of Pre-decision Conference ( PDF 25.95 KB ) | 28 Nov 2014 | |
| ACCC to Interested Parties re Pre-Decision Conference ( PDF 105.98 KB ) | 5 Nov 2014 | |
| ACCC to Applicant re Pre-Decision Conference ( PDF 112.28 KB ) | 5 Nov 2014 | |
| Applicant ( PDF 80.54 KB ) | 31 Oct 2014 | |
| RACGP to ACCC re Request for Pre-decision Conference ( PDF 36.54 KB ) | 30 Oct 2014 | |
| Show all documents (3 more) | ||